Severe obesity in childhood and adolescence more than triples the risk of MS, and obesity treatment does not seem to reverse it, a study finds.
A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback